Avalo Therapeutics

Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing novel therapies for immune dysregulation disorders. Their pipeline focuses on first-in-class biologics targeting dysregulated inflammation, with a particular emphasis on high-value potential. Their lead asset, AVTX-009, is an anti-IL-1β mAb aimed at treating inflammatory diseases. Their pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Avalo's team boasts deep expertise in disease pathology and clinical development, bringing a wealth of knowledge to their pursuit of innovative treatments. They are committed to a collaborative approach, fostering a culture of teamwork and passion for science. Their focus on developing meaningful medical impact is reflected in their active engagement with patient advocacy groups and their commitment to providing access to investigational therapies for patients with unmet medical needs.

Avalo Therapeutics offers a comprehensive and competitive benefits package designed to support employees, their partners, and their children. The benefits package is designed to meet the needs of their diverse workforce, and it includes a range of options to help employees achieve their health and financial goals.

Avalo Therapeutics is a clinical stage biotechnology company focused on developing first-in-class biologic therapies targeting immune dysregulation. Their mission is to create innovative treatments for serious and rare inflammatory diseases, focusing on areas like autoimmune and autoinflammatory disorders, non-eosinophilic asthma, acute respiratory distress syndrome, and inflammatory bowel disease. Avalo is committed to providing potentially life-saving therapies to patients while prioritizing patient advocacy and access to investigational therapies.

Avalo Therapeutics fosters a culture of compassion, teamwork, and dedication to scientific advancement. They prioritize the needs of patients suffering from inflammatory disorders and aim to create a supportive and collaborative environment where employees can utilize their talents and experience to achieve their shared goals. This is reflected in their commitment to a comprehensive and competitive benefits package for their employees and their efforts to create a diverse and inclusive workplace.

Avalo Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace. They actively recruit, hire, train, and promote individuals from all backgrounds, ensuring a workplace free from discrimination based on race, color, religion, national origin, gender, age, sexual orientation, veteran status, citizenship, marital status, or the presence of any sensory, mental, or physical impairment. They aim to create an environment where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents.